Effects of bevacizumab on retinal function in isolated vertebrate retina

BACKGROUND: Bevacizumab (Avastin) is a recombinant protein that targets vascular endothelial growth factor (VEGF). In vitro, bevacizumab inhibits VEGF induced cell proliferation and tissue factor production. Abnormal angiogenesis involving VEGF is a central event during the development of choroidal...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lüke, M, Warga, M, Ziemssen, F, Gelisken, F, Grisanti, S, Schneider, T, Lüke, C, Partsch, M, Bartz‐Schmidt, K U, Szurman, P
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2006
Témata:
Laboratory Science - Extended Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857377/
https://ncbi.nlm.nih.gov/pubmed/16754646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.094995
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky